Document Detail

Olmesartan and intestinal adverse effects in the ROADMAP study.
MedLine Citation:
PMID:  23218089     Owner:  NLM     Status:  MEDLINE    
Jan Menne; Hermann Haller
Related Documents :
3396119 - Microsomal metabolism of picene.
19302549 - Combined monitoring of changes in delta13ch4 and archaeal community structure during me...
20650249 - Evaluation of drug interactions in intact hepatocytes: inhibitors of terfenadine metabo...
20112299 - The effect of co-administered flavonoids on the metabolism of hesperetin and the dispos...
144749 - Rat intestinal metabolism of crufomate (4-tert-butyl-2-chlorophenyl methyl methylphosph...
9408089 - Dexamethasone metabolism in vitro: species differences.
2565209 - Spironolactone metabolism in target tissues. characteristics of deacetylation in kidney...
22349139 - In vitro identification of the cytochrome p450 isozymes involved in the n-demethylation...
736789 - Role of liver glutathione in 1,1-dichloroethylene metabolism and hepatotoxicity in inta...
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  87     ISSN:  1942-5546     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-11     Completed Date:  2013-03-12     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  England    
Other Details:
Languages:  eng     Pagination:  1230-1; author reply 1232     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II Type 1 Receptor Blockers / adverse effects*
Diarrhea / chemically induced*
Imidazoles / adverse effects*
Intestines / pathology*
Stomach / pathology*
Tetrazoles / adverse effects*
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Imidazoles; 0/Tetrazoles
Comment On:
Mayo Clin Proc. 2012 Aug;87(8):732-8   [PMID:  22728033 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score.
Next Document:  Defining the epidemiology of bloodstream infections: the 'gold standard' of population-based assessm...